Search

Your search keyword '"Chang BH"' showing total 242 results

Search Constraints

Start Over You searched for: Author "Chang BH" Remove constraint Author: "Chang BH"
242 results on '"Chang BH"'

Search Results

1. YM155 potently kills acute lymphoblastic leukemia cells through activation of the DNA damage pathway

3. End-of-life spiritual care at a VA medical center: Chaplains' perspectives.

5. The Combined Effect of Relaxation Response and Acupuncture on Quality of Life in Patients with HIV: A Pilot Study.

6. Optimizing early phase clinical trial washout periods: a report from the Therapeutic Advances in Childhood Leukemia and Lymphoma consortium.

7. Multi-Team Shared Expectations Tool (MT-SET): An Exercise to Improve Teamwork Across Health Care Teams.

8. Clonally related benign cephalic histiocytosis, histiocytic sarcoma, and T-cell acute lymphoblastic leukemia: Expanding the spectrum of histiocytic transdifferentiation.

9. Sgabd-2 plays specific role in immune response against biopesticide Metarhizium anisopliae in Aphis citricola.

10. The genomic basis of childhood T-lineage acute lymphoblastic leukaemia.

11. In vivo Targeting MEK and TNK2/SRC pathways in PTPN11 driven leukemia.

12. FDG PET/CT Imaging 1 Week after a Single Dose of Pembrolizumab Predicts Treatment Response in Patients with Advanced Melanoma.

14. NDUFS4 regulates cristae remodeling in diabetic kidney disease.

15. Conditional hepatocyte ablation of PDIA1 uncovers indispensable roles in both APOB and MTTP folding to support VLDL secretion.

16. Nivolumab Plus 5-Azacitidine in Pediatric Relapsed/Refractory Acute Myeloid Leukemia (AML): Phase I/II Trial Results from the Therapeutic Advances in Childhood Leukemia and Lymphoma (TACL) Consortium.

18. ROBO1 deficiency impairs HSPC homeostasis and erythropoiesis via CDC42 and predicts poor prognosis in MDS.

19. Clinical Correlates of Venetoclax-Based Combination Sensitivities to Augment Acute Myeloid Leukemia Therapy.

20. Patient-Specific Targeting of the T-Cell Receptor Variable Region as a Therapeutic Strategy in Clonal T-Cell Diseases.

21. The non-cell-autonomous function of ID1 promotes AML progression via ANGPTL7 from the microenvironment.

22. The transcription factor ChREBP links mitochondrial lipidomes to mitochondrial morphology and progression of diabetic kidney disease.

24. NDUFS4 Regulates Cristae Remodeling in Diabetic Kidney Disease.

25. Carbon emissions and the rising effect of trade openness and foreign direct investment: Evidence from a threshold regression model.

26. Subunit vaccines with a saponin-based adjuvant boost humoral and cellular immunity to MERS coronavirus.

28. Transplantation and immigration: Comparing infectious complications and outcomes between foreign-born and US-born kidney transplant recipients in Minnesota.

29. Inhibition of USP1 reverses the chemotherapy resistance through destabilization of MAX in the relapsed/refractory B-cell lymphoma.

30. Fetal Hepatomegaly.

31. Integrative analysis of drug response and clinical outcome in acute myeloid leukemia.

32. Associating drug sensitivity with differentiation status identifies effective combinations for acute myeloid leukemia.

33. Decitabine and vorinostat with FLAG chemotherapy in pediatric relapsed/refractory AML: Report from the therapeutic advances in childhood leukemia and lymphoma (TACL) consortium.

34. Schwann Cells Accelerate Osteogenesis via the Mif/CD74/FOXO1 Signaling Pathway In Vitro.

35. Exchange rate response to economic policy uncertainty: evidence beyond asymmetry.

36. Asymmetric effect of COVID-19 pandemic on E7 stock indices: Evidence from quantile-on-quantile regression approach.

37. Aurora A kinase as a target for therapy in TCF3-HLF rearranged acute lymphoblastic leukemia.

38. Synbiotic Intervention with an Adlay-Based Prebiotic and Probiotics Improved Diet-Induced Metabolic Disturbance in Mice by Modulation of the Gut Microbiota.

39. PGC1α is required for the renoprotective effect of lncRNA Tug1 in vivo and links Tug1 with urea cycle metabolites.

40. Factors and Outcomes Related to the Use of Guideline-Recommended Antibiotics in Patients With Neutropenic Fever at the Uganda Cancer Institute.

41. Concomitant use of a dual Src/ABL kinase inhibitor eliminates the in vitro efficacy of blinatumomab against Ph+ ALL.

43. Oil prices and E7 stock prices: an asymmetric evidence using multiple threshold nonlinear ARDL model.

44. Role for carbohydrate response element-binding protein (ChREBP) in high glucose-mediated repression of long noncoding RNA Tug1.

45. Simultaneous kinase inhibition with ibrutinib and BCL2 inhibition with venetoclax offers a therapeutic strategy for acute myeloid leukemia.

46. Decitabine and Vorinostat with Chemotherapy in Relapsed Pediatric Acute Lymphoblastic Leukemia: A TACL Pilot Study.

47. Growth Performance and Enzymatic Response of the Grasshopper, Calliptamus abbreviatus (Orthoptera: Acrididae), to Six Plant-Derived Compounds.

48. Phenotypic and Transcriptomic Response of the Grasshopper Oedaleus asiaticus (Orthoptera: Acrididae) to Toxic Rutin.

49. Reducing Three Infections Across Cardiac Surgery Programs: A Multisite Cross-Unit Collaboration.

50. Replication timing alterations in leukemia affect clinically relevant chromosome domains.

Catalog

Books, media, physical & digital resources